Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Clinical trial NCT06750484 · RECRUITING

Trial details

NCT number: NCT06750484
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2025-06-20
Primary completion: 2028-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.